English 

 Start 
 About Hebi 
 Investor relations 
 News 
 Operations 

 2010-09-10

 Fine Chemicals

Hebi Pharmaceutical Raw Materials

For more details click on thumnails or go into  Googel Earth Beta 4 v version (release sept 13, 2006) at coordinats 25 59 20 N, 32 52 34 E

Business Concept
Hebi Pharmaceutical Raw Materials business concept is to produce, promote and sell on the world market, pharmaceutical substances. Today Hebi manufactures the base product Cephalosporin C, the intermediate 7-ACA and API´s (Active pharmaceutical ingrediants) based on 7-ACA. 

Market
The world market for Cefalosporines, of the typ 7-ACA and  related API's, has grown from about 3.200 tonnes annualy 2003, to over 4.000 tonnes 2005. The largets markets are in China and there it is expected to grow between 6-8 % per year until the year 2010.

Cefalosporins
Cefalosporins were discovered in 1948 by professer Brotzu at the university of Cagliary, when these micro-organisms were shown to pocess antibiotic caracterisistics. Today Cefalosporins are produced industially and allthough they are closely related to penicillin (as both have a betalactama nucleus) they can be used to fight bacterier, that have built up a resistants against penecillin. 
In order to circumvent infections during inplant operations of artificial heart valvs, limb joints etc,  Prophylatic antibiotics are used as a preventive messure and it is here that Cefalosorins have also a large market. 

The first steps of production takes place in our lab. There our micro biological and technical staff, through rigerous analys make sure that all of the basic componants and ingredienses are of the right values .

The pictures above are from our pilot plant. This is where we can test our manufacturing process and train up our staff.

Here can we see the pipe racks that join together different satges of the production process. the two other pictures shows products in the stores reday for shippment.